Interius Biotherapeutics
Scott is focused on planning new programs and deriving value from our company’s ongoing work through IP generation and capture. Scott is a genetic engineer with over a decade of experience in the fields of genetics and gene therapy. Throughout his career he has integrated computer and biological sciences to design and implement creative gene therapy strategies. Prior to joining Interius he worked at Spirovant Sciences, and previously at Limelight Bio developing lentivirus and AAV platforms for the treatment of diseases with unmet needs.
Scott received his BA degree in Genetics from Rutgers University and his Ph.D. in Cellular and Molecular Biology, with a concentration in Gene Therapy, from the University of Pennsylvania.
This person is not in any teams
Interius Biotherapeutics
1 followers
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.